• Welcome to Crohn's Forum, a support group for people with all forms of IBD. While this community is not a substitute for doctor's advice and we cannot treat or diagnose, we find being able to communicate with others who have IBD is invaluable as we navigate our struggles and celebrate our successes. We invite you to join us.

New drug for Crohn's disease shows early promise

Last edited:

Lady Organic

Moderator
Staff member
from the article: ''Because the active compound of mongersen is released in the terminal ileum and right (proximal) colon, we excluded patients with known lesions in the stomach, proximal small intestine, transverse colon, or left colon.''

This treatment seems promising. Hopefully they can come up with a component that can be released anywhere/everywhere in the digestive track.
 
I´m going to be negative and say, we don´t need these maintenance drugs. We need a CURE god damn it! But off course I do understand the purpose and companies are still trying to make money out of us, as much as they can. That keeps moving things forward, but I´m betting all my money on Professor John-Hermon Taylor and Thomas Borody.

Anti MAP vaccine
 
I´m going to be negative and say, we don´t need these maintenance drugs. We need a CURE god damn it! But off course I do understand the purpose and companies are still trying to make money out of us, as much as they can. That keeps moving things forward, but I´m betting all my money on Professor John-Hermon Taylor and Thomas Borody.

Anti MAP vaccine
That is pretty negative, considering these researchers are dedicating their lives to trying to help you (and all of us).

What if the MAP vaccine (which is not the subject of this thread btw) is a failure? Should we not try anything else since you have an unproven belief in it?
 
That is pretty negative, considering these researchers are dedicating their lives to trying to help you (and all of us).

What if the MAP vaccine (which is not the subject of this thread btw) is a failure? Should we not try anything else since you have an unproven belief in it?
I tend to agree with the position that we should keep an open mind about the cause of Crohn's. It could be MAP, it could be IEC, it could be dysbiosis, it could be immune dysfunction. Until a definitive cause is found and subsequently a cure, it is important to treat the disease and keep its damaging effects at bay. These antisense drugs provide a lower risk profile than some of the current treatments, so it's a positive development that should be welcomed.

Yes, drug companies want to make a profit. They are no different than any other business, and they need to be rewarded for the capital risks they take. I would rather that they are there looking for safer, more effective treatment than they not be there at all. Even socially conscious businesses must operate from a profit perspective or else they will not last.

And don't be surprised if when Dr. Hermon-Taylor's MAP vaccine proves out in early stage trials, he license it to a big pharma company. It's the nature of the business. Researchers have to license out their discoveries to bring them to market. It won't happen otherwise. Dr. Borody sold his formulation to RedHill Bio to take to Phase III trials.
 
just fixed it!

resveratrol tgf-beta.
http://onlinelibrary.wiley.com/doi/10.1002/ibd.21843/pdf

i use resveratrol and it make a difference in how i feel and my observable symptoms.
Wildbill, this was very interesting (thanks!) but also raises a few questions.

The new drug down regulates SMAD7, which in turn inhibits TGFbeta-1. They state in the trial report that TGfbeta-1 is an immunosuppressive cytokine. Thus this lowers inflammation by effectively increasing TGFbeta-1. However, in the resveratrol study you linked, the 100mg/kg dose actually lowered TGFbeta-1. Furthermore, in the resveratrol study they state that TGFbeta-1 is a profibrotic factor (causing fibrosis and strictures). Anyway, it seems that (at a high enough dose) resveratrol actually does the opposite of what this drug tries to do. However, pro-inflammatory cytokines were also decreased with intake of resveratrol, but through other mechanisms. If TGFbeta-1 is indeed fibrotic this will likely show up in long term use of the new drug. Resveratrol seems to be very beneficial but it doesn't seem to help TGFbeta-1 like the new drug does.
 
Top